Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

2articles mentioning drugs

7drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: sotatercept ×

sotatercept

This drug is selected. Its supporting articles are shown below.

Sotatercept2

Articles mentioning sotatercept

2 articles · page 1 of 1

Protocol for an open-label, randomised, controlled trial to evaluate the efficacy and safety of sotatercept add-on therapy compared with pulmonary vasodilator-based standard of care for pulmonary vasodilator-resistant pulmonary arterial hypertension associated with unrepaired congenital shunts (atrial septal defect, ventricular septal defect or patent ductus arteriosus), including Eisenmenger syndrome: the SuMILE trial

bmjopen · abstract · 2026-03-12 · 4 matching annotations

99.2%

Sotatercept Eisenmenger syndrome pulmonary arterial hypertension (PAH)vasodilator-based PAH therapy atrial septal defect ventricular septal defect

…nefit, and no disease-modifying treatment has been established. Sotatercept, an activin-signalling inhibitor, improved exercise capacity an…

Postmarketing analysis of sotatercept: identifying serious unlabelled events

openhrt · abstract · 2025-09-30 · 3 matching annotations

99.5%

Sotatercept sotatercept-associated pulmonary arterial hypertension FDA

…Purpose Sotatercept, an activin signalling inhibitor approved in March 2024 for pul…